Cynata Therapeutics (ASX:CYP): Interview with CEO Dr. Ross Macdonald

October 14, 2021

Cynata Therapeutics, CYP

Summary

We talked with Cynata Therapeutics CEO Dr. Ross Macdonald about the multiple clinical-stage opportunities the Cymerus technology has created, including its potential use in COVID-19 where a trial is now underway.

 

Read our most recent article on CYP here